So far I have made *$710.00 selling Celgene Corp (CELG) Puts and *$760.00 selling Bristol-Myers Squibb (BMY) Puts in 2019, but I still don’t own any shares. Bristol-Myers Squibb […]
The Stock Market is tanking today due to Donald Trump’s trade war with China, so I broke out my shopping list. Albemarle is the dominant […]
You may recall that I made *$710.00 selling Celgene Corp (CELG) Puts earlier this year – but had I simply bought 500 shares instead of selling Puts […]
Back in December 2018, I was put 500 shares of Anheuser-Busch InBev (BUD). My entry price was $68.24 per share – almost a 42% discount to […]
It was fun while it lasted – but the US Stock Market is back to being overvalued. My stock exposure is sitting at 20% (based […]
First headline I read today: MarketWatch – Bristol-Myers to acquire Celgene in cash-and-stock deal with equity value of about $74 billion I closed out the five […]
Stocks are starting to get cheap (at least some stocks by some metrics) – time to buy. I was put 500 shares of Anheuser-Busch InBev (BUD) on […]
The Market is crashing again today – time to shop! I sold options on Enbridge Inc. (ENB) again, since I still believe the shares are deeply undervalued. Here […]
Today I sold Put options on a new master limited partnership (MLP) – Enterprise Products Partners L.P. (EPD). You may ask why I chose them over Enbridge […]
Biotech stocks have been hit hard all year, and especially in the last two Months – I might be early to this trade, but Celgene […]
Copyright © 2026 | WordPress Theme by TodayTrader
